A Phase 1/Phase 2 Study of Polyvalent Pneumococcal Conjugate Vaccine (V116) in Adults (V116-001)

Clinical trial NCT04168190 · COMPLETED

Trial details

NCT number: NCT04168190
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pneumonia, Pneumococcal

Start date: 2019-12-06
Primary completion: 2021-07-12
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.